STK11 and non-small cell lung carcinoma: Our findings are in line with recent clinical observations showing that STK11 and KEAP1 co-mutations are significantly associated with “desert” or PD-L1–negative immune phenotypes in NSCLC, supporting the link between LKB1 loss, low DPP4 expression, and an immune-cold TME (11).